Protagonist Therapeutics, Inc. (PTGX) Presents At Citi's Biopharma Back To School Conference Transcript

Core Insights - The company is focused exclusively on peptide therapeutics, emphasizing the versatility of its platform which is agnostic to disease areas or targets [2][3] - The company aims to avoid scenarios where scientific success does not translate into practical utility for drugs, highlighting the importance of both scientific and commercial viability [2] Group 1 - The peptide platform is viewed as a renewable resource, with potential for greater value in the future [1] - The company seeks strong differentiation in its approach to peptide therapeutics, ensuring that scientific achievements align with market needs [3]